Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 7 | 2019 | 204 | 1.110 |
Why?
|
| Benzoquinones | 6 | 2022 | 38 | 1.000 |
Why?
|
| Allyl Compounds | 5 | 2024 | 53 | 0.690 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2019 | 184 | 0.680 |
Why?
|
| Neuroprotective Agents | 4 | 2025 | 267 | 0.560 |
Why?
|
| Garlic | 4 | 2024 | 31 | 0.470 |
Why?
|
| Gene Expression Regulation | 3 | 2019 | 1066 | 0.440 |
Why?
|
| Oxidative Stress | 3 | 2025 | 990 | 0.430 |
Why?
|
| Hydrolyzable Tannins | 3 | 2019 | 20 | 0.420 |
Why?
|
| Precancerous Conditions | 2 | 2024 | 83 | 0.400 |
Why?
|
| Lipopolysaccharides | 7 | 2018 | 235 | 0.380 |
Why?
|
| Receptors, CCR3 | 2 | 2009 | 10 | 0.380 |
Why?
|
| Pulmonary Alveoli | 2 | 2009 | 27 | 0.370 |
Why?
|
| Manganese Compounds | 1 | 2012 | 15 | 0.370 |
Why?
|
| Chlorides | 1 | 2012 | 59 | 0.360 |
Why?
|
| Chemokines, CC | 2 | 2009 | 53 | 0.360 |
Why?
|
| Sulfides | 3 | 2024 | 77 | 0.340 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 310 | 0.340 |
Why?
|
| Down-Regulation | 3 | 2022 | 452 | 0.340 |
Why?
|
| Antioxidants | 4 | 2024 | 439 | 0.330 |
Why?
|
| Cytokines | 4 | 2018 | 661 | 0.310 |
Why?
|
| Interleukin-4 | 1 | 2008 | 75 | 0.290 |
Why?
|
| Cell Survival | 7 | 2017 | 934 | 0.280 |
Why?
|
| Mitochondria | 1 | 2012 | 516 | 0.280 |
Why?
|
| RNA Interference | 1 | 2008 | 246 | 0.270 |
Why?
|
| Interferon-gamma | 5 | 2018 | 268 | 0.250 |
Why?
|
| RNA, Messenger | 5 | 2022 | 1265 | 0.250 |
Why?
|
| Peroxisomes | 1 | 2025 | 3 | 0.240 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 1112 | 0.240 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2025 | 48 | 0.230 |
Why?
|
| Biological Products | 2 | 2016 | 91 | 0.230 |
Why?
|
| Cell Line, Tumor | 9 | 2024 | 2598 | 0.230 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2025 | 83 | 0.230 |
Why?
|
| Benzo(a)pyrene | 3 | 2024 | 128 | 0.220 |
Why?
|
| Gene Expression | 3 | 2022 | 692 | 0.220 |
Why?
|
| Kidney Neoplasms | 1 | 2025 | 77 | 0.220 |
Why?
|
| Metformin | 1 | 2025 | 74 | 0.220 |
Why?
|
| Anticarcinogenic Agents | 1 | 2024 | 74 | 0.200 |
Why?
|
| Disulfides | 2 | 2014 | 92 | 0.190 |
Why?
|
| Breast Neoplasms | 2 | 2024 | 1679 | 0.190 |
Why?
|
| Phytotherapy | 1 | 2021 | 78 | 0.180 |
Why?
|
| Flavonoids | 1 | 2021 | 94 | 0.160 |
Why?
|
| Animals | 11 | 2025 | 16695 | 0.160 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2021 | 134 | 0.160 |
Why?
|
| Hydrogen Peroxide | 3 | 2022 | 193 | 0.160 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2017 | 456 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2021 | 979 | 0.160 |
Why?
|
| High-Throughput Screening Assays | 2 | 2016 | 72 | 0.150 |
Why?
|
| Humans | 19 | 2025 | 42163 | 0.150 |
Why?
|
| Cell Line, Transformed | 2 | 2017 | 96 | 0.150 |
Why?
|
| NF-kappa B | 2 | 2018 | 355 | 0.150 |
Why?
|
| Mice | 7 | 2019 | 6490 | 0.150 |
Why?
|
| Cell Proliferation | 6 | 2023 | 1420 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2017 | 128 | 0.140 |
Why?
|
| Inflammation | 2 | 2025 | 729 | 0.140 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 379 | 0.140 |
Why?
|
| Butyric Acid | 1 | 2017 | 19 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 1 | 1 | 2017 | 14 | 0.130 |
Why?
|
| Valproic Acid | 1 | 2017 | 21 | 0.130 |
Why?
|
| Inflammation Mediators | 1 | 2018 | 138 | 0.130 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2017 | 33 | 0.130 |
Why?
|
| Chemokine CXCL2 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Nitrogen Dioxide | 1 | 2016 | 17 | 0.130 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 189 | 0.130 |
Why?
|
| RNA, Small Interfering | 2 | 2009 | 436 | 0.130 |
Why?
|
| Manganese | 1 | 2017 | 89 | 0.120 |
Why?
|
| Proteomics | 2 | 2019 | 363 | 0.120 |
Why?
|
| Glioma | 1 | 2016 | 92 | 0.120 |
Why?
|
| Sepsis | 1 | 2016 | 90 | 0.120 |
Why?
|
| Nitrites | 1 | 2015 | 54 | 0.120 |
Why?
|
| Astrocytes | 1 | 2017 | 244 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2021 | 501 | 0.110 |
Why?
|
| Lysine | 1 | 2015 | 120 | 0.110 |
Why?
|
| Motor Activity | 1 | 2017 | 438 | 0.110 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2014 | 31 | 0.110 |
Why?
|
| Cell Line | 4 | 2019 | 1416 | 0.110 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 972 | 0.110 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 518 | 0.110 |
Why?
|
| Superoxides | 2 | 2016 | 57 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2016 | 461 | 0.100 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 95 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2015 | 457 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 415 | 0.100 |
Why?
|
| Proteome | 1 | 2014 | 150 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 2 | 2 | 2023 | 16 | 0.100 |
Why?
|
| Macrophages | 1 | 2016 | 515 | 0.100 |
Why?
|
| Estradiol | 1 | 2014 | 269 | 0.090 |
Why?
|
| Heme Oxygenase-1 | 1 | 2012 | 52 | 0.090 |
Why?
|
| PC12 Cells | 1 | 2012 | 93 | 0.090 |
Why?
|
| Carcinogens | 1 | 2012 | 126 | 0.090 |
Why?
|
| Apoptosis | 4 | 2024 | 1541 | 0.090 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2022 | 89 | 0.090 |
Why?
|
| Lactic Acid | 1 | 2012 | 110 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 165 | 0.090 |
Why?
|
| DNA Damage | 3 | 2024 | 358 | 0.080 |
Why?
|
| Glucose | 1 | 2012 | 242 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2022 | 534 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 458 | 0.080 |
Why?
|
| Eosinophils | 1 | 2009 | 22 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2012 | 303 | 0.080 |
Why?
|
| Chemokine CCL24 | 1 | 2008 | 2 | 0.080 |
Why?
|
| Glutathione | 2 | 2022 | 170 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2025 | 933 | 0.070 |
Why?
|
| Rats | 2 | 2016 | 3701 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 683 | 0.070 |
Why?
|
| Female | 6 | 2025 | 24018 | 0.070 |
Why?
|
| Ligands | 1 | 2008 | 387 | 0.070 |
Why?
|
| Time Factors | 1 | 2012 | 1848 | 0.070 |
Why?
|
| Protein Array Analysis | 2 | 2017 | 27 | 0.060 |
Why?
|
| Cell Movement | 1 | 2009 | 640 | 0.060 |
Why?
|
| Epithelial Cells | 2 | 2024 | 426 | 0.060 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 1068 | 0.060 |
Why?
|
| Asthma | 1 | 2009 | 410 | 0.060 |
Why?
|
| Cytochrome P-450 CYP1A1 | 1 | 2024 | 52 | 0.050 |
Why?
|
| Nitric Oxide | 2 | 2017 | 381 | 0.050 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2023 | 5 | 0.050 |
Why?
|
| Prognosis | 1 | 2025 | 850 | 0.050 |
Why?
|
| Chemokines | 1 | 2023 | 97 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2023 | 226 | 0.050 |
Why?
|
| DNA Repair | 1 | 2024 | 196 | 0.050 |
Why?
|
| Catechin | 1 | 2022 | 38 | 0.050 |
Why?
|
| DNA | 1 | 2024 | 594 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 274 | 0.040 |
Why?
|
| Neurodegenerative Diseases | 1 | 2019 | 138 | 0.030 |
Why?
|
| Rotarod Performance Test | 1 | 2017 | 14 | 0.030 |
Why?
|
| Cerebellum | 1 | 2017 | 78 | 0.030 |
Why?
|
| Lipid Peroxides | 1 | 2016 | 19 | 0.030 |
Why?
|
| Aging | 1 | 2022 | 764 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 95 | 0.030 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2016 | 122 | 0.030 |
Why?
|
| Catalase | 1 | 2016 | 111 | 0.030 |
Why?
|
| Male | 3 | 2025 | 22779 | 0.030 |
Why?
|
| Neutrophils | 1 | 2016 | 141 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2016 | 158 | 0.030 |
Why?
|
| Analysis of Variance | 1 | 2017 | 574 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2017 | 303 | 0.030 |
Why?
|
| Adipokines | 1 | 2014 | 25 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 506 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 7982 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2012 | 41 | 0.020 |
Why?
|
| Comet Assay | 1 | 2012 | 77 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 1804 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2012 | 348 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2012 | 411 | 0.020 |
Why?
|
| Middle Aged | 1 | 2025 | 11819 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2018 | 2111 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2009 | 1617 | 0.010 |
Why?
|